The Coca-Cola Company is the target of a proposed class suit alleging that it deceptively portrays Minute Maid juice as a healthy alternative to fresh fruit despite the drinks containing high amounts of sugar, which increases the risk of chronic disease
Coca-Cola is accused of exploiting consumers' predilection for healthy foods by positioning the Juice Boxes as healthy alternatives, especially by directly pushing wellness and health-related topics on their labeling and packaging.
Minute Maid juice boxes are allegedly mislabeled with the phrases “Good for You!” and “Part of a Healthy, Balanced Diet.”
According to the proposed class suit, a six-fluid-ounce serving of a Minute Maid juice box, including the apple, apple white grape, mixed berry, fruit punch, and lemonade flavors, contains between 19 and 21 grams of free sugar, constituting nearly all each box’s calories.
Given that fruit juices have been connected to an increased risk of heart disease, type 2 diabetes, obesity, and metabolic syndrome, among other major chronic problems, the 53-page complaint claims that Coca-Cola's health representations are "false and deceptive."
The suit noted that a piece of fruit, while healthy when eaten whole, “is transformed into a decidedly unhealthy food once processed into juice.
The lawsuit asserts that Coca-Cola preys on preexisting beliefs that juice is healthful amid a “disinformation campaign” about the health effects of sugar.
The lawsuit seeks to represent all Americans who purchased Minute Maid juice cartons for domestic or personal use alone throughout the preceding four years.


Gold Prices Retreat From Two-Month High as Softer Inflation Eases Fed Rate Hike Bets
Asian Currencies Steady as Dollar Holds Firm After U.S. Inflation Data
Trump Election Order Blocked Again as Appeals Court Rejects Mail-In Voting Push in 23 States
Super Micro Stock Jumps 19% as AI Server Demand Drives Strong 2027 Outlook
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Alphabet Shifts AI Strategy Toward Commercial Growth, Goldman Sachs Says
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Micron Stock Upgraded to Buy as New Street Sees $2 Trillion Valuation Potential
Strait of Hormuz Shipping Near Standstill After New Vessel Attacks
Bill Ackman’s Pershing Square Returns to Netflix With Major New Stake
S&P 500 Hits Record High as Soft Inflation Data Eases Fed Rate Hike Fears
Maduro, U.S. Prosecutors Propose June 2027 Trial Date in Drug Trafficking Case
Stripe, Advent Reportedly Pursue $53 Billion PayPal Takeover
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Oil Prices Slide as OPEC, IEA Cut 2026 Demand Forecasts
Trump Signs Order to Cut Routine Childhood Vaccines
Alphabet’s SpaceX Investment Soars 100-Fold to $94 Billion 



